CML Ponatinib vs Bosutinib: What is Next for Research? #ASH19 @TakedaOncology

Shouryadeep Srivastava, MBBS, PhD of @TakedaOncology discusses CML patients prescribed ponatinib vs bosutinib: what is next for research?